MedTrace Logo

Cryoablation of Bone Metastases From Endocrine Tumors

NCT03986593 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2023-07-05

No results posted yet for this study

Summary

This study will evaluate the clinical response and safety of cone beam computed-tomography guided percutaneous cryoablation in bone metastases from thyroid, adrenal and neuroendocrine tumors in 30 patients.

Conditions

Interventions

DEVICE

cryoablation

cryoablation of bone metastases by cone beam-CT image-guidance

Sponsors & Collaborators

  • University of Sao Paulo General Hospital

    collaborator OTHER

  • Instituto do Cancer do Estado de São Paulo

    lead OTHER

Principal Investigators

  • Ricardo MC Freitas, PhD · Instituto do Cancer do Estado de São Paulo

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-26
Primary Completion
2022-10-15
Completion
2023-05-29
FDA Device
Yes

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03986593 on ClinicalTrials.gov